menu
    • menu

    Company profile for VBL Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. We are focused on the discovery, development and commercialization of first-in-class treatments for cancer. VBL has pioneered and is actively developing three novel platform technologies. The Company’s most advanced program is ...
    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. We are focused on the discovery, development and commercialization of first-in-class treatments for cancer. VBL has pioneered and is actively developing three novel platform technologies. The Company’s most advanced program is the anti-cancer gene-therapy program, in which VB-111 is the lead candidate. VB-111 is positioned to potentially treat a wide range of solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VBL TherapeuticsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    8 HaSatat St. Modi’in
    Telephone
    Telephone
    972-8-9935000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vblrx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting
    VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting

    12 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/12/2759289/0/en/VBL-Therapeutics-Announces-Results-of-Annual-and-Special-Shareholder-Meeting.html

    GLOBENEWSWIRE
    12 Oct 2023
    Share Share
    VBL Therapeutics Reminds Shareholders to Vote in the Annual Meeting
    VBL Therapeutics Reminds Shareholders to Vote in the Annual Meeting

    04 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/04/2754511/0/en/VBL-Therapeutics-Reminds-Shareholders-to-Vote-in-the-Upcoming-Annual-and-Special-Shareholder-Meeting.html

    GLOBENEWSWIRE
    04 Oct 2023
    Share Share
    VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger
    VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger

    06 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/06/2738347/0/en/VBL-Therapeutics-Announces-that-S-4-Registration-Statement-for-Proposed-Merger-with-Notable-Labs-Is-Declared-Effective-by-SEC.html

    GLOBENEWSWIRE
    06 Sep 2023
    Share Share
    VBL Therapeutics Reports Second Quarter 2023 Financial Results
    VBL Therapeutics Reports Second Quarter 2023 Financial Results

    14 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/14/2724325/0/en/VBL-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    14 Aug 2023
    Share Share
    VBL Therapeutics Reports 1Q 2023 FYR Results and Provides Business Update
    VBL Therapeutics Reports 1Q 2023 FYR Results and Provides Business Update

    15 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/15/2669270/0/en/VBL-Therapeutics-Reports-First-Quarter-2023-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    15 May 2023
    Share Share
    VBL Therapeutics Reports Full Year 2022 Financial Results
    VBL Therapeutics Reports Full Year 2022 Financial Results

    14 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/14/2626587/0/en/VBL-Therapeutics-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    14 Mar 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search